News Conference News TCT 2025 Ultrathin-Strut DES Performs Well vs Xience in Diabetic Patients: TUXEDO-2 Todd Neale November 03, 2025
News Industry News SMT’s Supraflex Cruz Shows Consistent and Robust Clinical Outcomes Across Key Global Studies Presented at TCT 2025 October 29, 2025
Presentation TCT 2024 TCT 424: Pathological Analysis of Fibrin Deposition Around Stent Struts Within 1 Month After Circumferentially Coated Durable Polymer Drug-Eluting Stents and Abluminally Coated Biodegradable Polymer Drug-Eluting Stents for ACS Presenter: Kazuki Aihara October 29, 2024
News Industry News Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients June 18, 2024
News Conference News TCT 2023 BIOSTEMI: Degradable-Polymer, Ultrathin-Strut DES Shows No Late Catch-up at 5 Years Caitlin E. Cox October 27, 2023
Presentation TCT 2023 Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free Presenter: Stephan Windecker October 26, 2023
Presentation TCT 2023 Long-Term Outcomes with Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction: 5-Year Follow-up of the Biostemi Randomized Trial Presenter: Juan Iglesias October 25, 2023
News Conference News ACC 2023 Short DAPT Noninferior to 1 Year After Ultrathin DES PCI: HOST-IDEA Yael L. Maxwell March 09, 2023
News Conference News TCT 2022 Late Catch-up Sours SUGAR for Polymer-Free Stent in Diabetic Patients Yael L. Maxwell September 27, 2022
Presentation TCT 2022 TCT 167: Percutaneous Coronary Intervention with Ultrathin-Strut Biodegradable versus Thin-Strut Durable Polymer Drug-Eluting Stents of Lesions Requiring Multiple Stents: A Lesion-Level Subgroup Analysis of the Combined BIOSCIENCE and BIOSTEMI Randomized… Presenter: Jonas Haener September 19, 2022
Presentation TCT 2022 TCT 51: Assessment of Durable Polymer and Biodegradable Polymer Drug-Eluting Stents After Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Presenter: Gustavo Araújo September 17, 2022
News Conference News BIOFLOW V: Orsiro Still Offers Some Benefits at 5 Years Caitlin E. Cox March 02, 2022
News Conference News In ACS, Clopidogrel Monotherapy After 1-Month DAPT Falls Short: STOPDAPT-2 ACS Shelley Wood August 30, 2021
News Conference News EuroPCR 2021 Ultrathin Orsiro Performs Well in All-Comers, Interim CASTLE Data Indicate Caitlin E. Cox May 24, 2021
News Conference News CRT 2021 BIOSTEMI at 2 Years: Orsiro Continues to Lower TLF in STEMI Patients Caitlin E. Cox March 16, 2021
News Daily News No Harm, No Help With Bioabsorbable-Polymer Stents: Registry Michael O'Riordan March 01, 2021
News Conference News ‘Healing’ Stent Noninferior to Permanent-Polymer Device: PIONEER III Shelley Wood November 19, 2020
Presentation TCT 2020 The HOST-Reduce-Polytech-ACS trial: Durable Polymer versus Biodegradable Polymer Drug-Eluting Stents after percutaneous coronary intervention in patients with Acute Coronary Syndrome Presenter: Hyo-Soo Kim October 17, 2020
Presentation TCT 2020 HOST-REDUCE-POLYTECH-ACS: A Randomized Trial of Durable Polymer vs Bioabsorbable Polymer DES in Patients With Acute Coronary Syndromes Presenter: Hyo-Soo Kim October 17, 2020